CNTO-5825

CAT: 0804-HY-P991258Size: 1 EachDry Ice: YesHazardous: No
CAT#:0804-HY-P991258Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
CNTO-5825 is a humanized monoclonal antibody inhibitor targeting interleukin-13 (IL-13) . CNTO-5825 is promising for research of Th2-type inflammatory related diseases such as asthma and atopic dermatitis[1].
UNSPSC
12352203
Target
Interleukin Related
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Smiles
[CNTO-5825]
References & Citations
[1]van Hartingsveldt B, et al. Safety, tolerability and pharmacokinetics of a human anti-interleukin-13 monoclonal antibody (CNTO 5825) in an ascending single-dose first-in-human study. Br J Clin Pharmacol. 2013 May;75 (5) :1289-98.
Shipping Conditions
Dry Ice
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 1
Isoform
IL-13

Related Products

CatalogName
HY-P991399CNTO-3157
HY-P991260CNTO-6785
HY-P991619CNTO-860
HY-P990332Anti-Amyloid Beta Antibody (CNTO 2125)
HY-P990442Anti-IL-13 Antibody (CNTO 607)
HY-117781GW-5823
HY-101384Ro 10-5824
HY-137849-01RK-582
HY-148274-01KTX-582
HY-105196DAT-582

Alternative Products

CatalogName
MF-0101462-01CNTO-5825
A136413Anti-IL13 (CNTO-5825) Biosimilar (Monoclonal, IgG)
MBS1581338-01Research Grade Anti-Human IL13 (CNTO-5825)
MF-0100733-01CNTO-6785
MF-0100802-01CNTO-3157
MF-0100631-01CNTO 607
MF-0100909-01CNTO-860
A2800-1mg*25Anti-Amyloid Beta (CNTO 2125)
C00562-01Anti-IL-13 (CNTO 607)
F1526-.1Anti-Amyloid Beta Antibody (CNTO 2125)

Popular Products